These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 25156678)

  • 1. Update on Clostridium difficile infections.
    Le Monnier A; Zahar JR; Barbut F
    Med Mal Infect; 2014 Aug; 44(8):354-65. PubMed ID: 25156678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of Clostridium difficile infection.
    Dupont HL
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1216-23; quiz e73. PubMed ID: 23542332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options.
    Lo Vecchio A; Zacur GM
    Curr Opin Gastroenterol; 2012 Jan; 28(1):1-9. PubMed ID: 22134217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of Clostridium difficile infection.
    Korman TM
    Semin Respir Crit Care Med; 2015 Feb; 36(1):31-43. PubMed ID: 25643269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridium difficile and the disease it causes.
    Norén T
    Methods Mol Biol; 2010; 646():9-35. PubMed ID: 20597000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection: update on diagnosis, epidemiology, and treatment strategies.
    To KB; Napolitano LM
    Surg Infect (Larchmt); 2014 Oct; 15(5):490-502. PubMed ID: 25314344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.
    Debast SB; Bauer MP; Kuijper EJ;
    Clin Microbiol Infect; 2014 Mar; 20 Suppl 2():1-26. PubMed ID: 24118601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile Infection.
    Knight CL; Surawicz CM
    Med Clin North Am; 2013 Jul; 97(4):523-36, ix. PubMed ID: 23809712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile colitis: review of the therapeutic approach.
    Joseph J; Singhal S; Patel GM; Anand S
    Am J Ther; 2014; 21(5):385-94. PubMed ID: 22990077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and control of Clostridium difficile infections in healthcare settings: an update.
    Barbut F; Jones G; Eckert C
    Curr Opin Infect Dis; 2011 Aug; 24(4):370-6. PubMed ID: 21505332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fidaxomicin for the treatment of Clostridium difficile infections.
    Whitman CB; Czosnowski QA
    Ann Pharmacother; 2012 Feb; 46(2):219-28. PubMed ID: 22318930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for Clostridium difficile infections in Baranya County, Southern Hungary.
    Vigvári S; Sipos D; Kappéter Á; Feiszt Z; Kovács B; Péterfi Z
    Acta Microbiol Immunol Hung; 2018 Jun; 65(2):183-192. PubMed ID: 29651860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection.
    Miller M
    Expert Opin Pharmacother; 2010 Jun; 11(9):1569-78. PubMed ID: 20446864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent epidemiology of Clostridium difficile infection in Japan].
    Yamagishi Y; Mikamo H
    Jpn J Antibiot; 2015 Dec; 68(6):345-58. PubMed ID: 27004398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging management options for Clostridium difficile infection: what is the role of fidaxomicin?
    Cornely OA
    Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():28-35. PubMed ID: 23121552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.